I-Ju Liu

3.0k total citations · 1 hit paper
22 papers, 2.0k citations indexed

About

I-Ju Liu is a scholar working on Molecular Biology, Biomedical Engineering and Infectious Diseases. According to data from OpenAlex, I-Ju Liu has authored 22 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Biomedical Engineering and 5 papers in Infectious Diseases. Recurrent topics in I-Ju Liu's work include Nanoplatforms for cancer theranostics (7 papers), Mosquito-borne diseases and control (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). I-Ju Liu is often cited by papers focused on Nanoplatforms for cancer theranostics (7 papers), Mosquito-borne diseases and control (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). I-Ju Liu collaborates with scholars based in Taiwan, United States and Vietnam. I-Ju Liu's co-authors include Han‐Chung Wu, Ruei‐Min Lu, Hsin‐Jung Li, Chi‐Chiu Lee, Chien‐Hsun Wu, Chien‐Yu Chiu, Yunching Chen, Yi‐Ping Wang, Mei‐Ying Liao and Pi‐Chun Li and has published in prestigious journals such as Journal of Biological Chemistry, Gut and Journal of Colloid and Interface Science.

In The Last Decade

I-Ju Liu

20 papers receiving 2.0k citations

Hit Papers

Development of therapeutic antibodies for the treatment o... 2020 2026 2022 2024 2020 400 800 1.2k

Peers

I-Ju Liu
Tristan J. Vaughan United Kingdom
Yariv Wine Israel
Partha S. Chowdhury United States
Nazzareno Dimasi United States
Arvind Rajpal United States
I-Ju Liu
Citations per year, relative to I-Ju Liu I-Ju Liu (= 1×) peers Ruei‐Min Lu

Countries citing papers authored by I-Ju Liu

Since Specialization
Citations

This map shows the geographic impact of I-Ju Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I-Ju Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I-Ju Liu more than expected).

Fields of papers citing papers by I-Ju Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I-Ju Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I-Ju Liu. The network helps show where I-Ju Liu may publish in the future.

Co-authorship network of co-authors of I-Ju Liu

This figure shows the co-authorship network connecting the top 25 collaborators of I-Ju Liu. A scholar is included among the top collaborators of I-Ju Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I-Ju Liu. I-Ju Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chiang, Wen‐Hsuan, et al.. (2025). Tannic acid/doxorubicin hybrid nano-assemblies decorated with D-α-tocopheryl polyethylene glycol succinate-conjugated pemetrexed to treat non-small cell lung cancer. Journal of the Taiwan Institute of Chemical Engineers. 172. 106115–106115.
2.
Lin, T., I-Ju Liu, Bor‐Show Tzang, et al.. (2025). Photothermal-enhanced ROS storm by hyaluronic acid-conjugated nanocatalysts to amplify tumor-specific photo-chemodynamic therapy and immune response. International Journal of Biological Macromolecules. 309(Pt 3). 142975–142975. 2 indexed citations
3.
Liu, I-Ju, T. Lin, Shang‐Hsiu Hu, et al.. (2025). Tumor-targeting Cu2+/IR820-rich nanozymes to exert photothermal-reinforced reactive oxygen species production and dual glutathione scavenging for synergistic cancer therapy. Journal of Colloid and Interface Science. 703(Pt 2). 139183–139183.
5.
Chen, Yu‐Hsin, I-Ju Liu, T. Lin, et al.. (2024). PEGylated chitosan-coated nanophotosensitizers for effective cancer treatment by photothermal-photodynamic therapy combined with glutathione depletion. International Journal of Biological Macromolecules. 266(Pt 2). 131359–131359. 17 indexed citations
6.
Lin, T., I-Ju Liu, Shang‐Hsiu Hu, et al.. (2024). Hyaluronic acid-covered ferric ion-rich nanobullets with high zoledronic acid payload for breast tumor-targeted chemo/chemodynamic therapy. International Journal of Biological Macromolecules. 279(Pt 3). 135271–135271. 5 indexed citations
7.
Chen, Xiaorui, I-Ju Liu, Chun‐Mei Hu, et al.. (2022). Structural basis of interleukin-17B receptor in complex with a neutralizing antibody for guiding humanization and affinity maturation. Cell Reports. 41(4). 111555–111555. 2 indexed citations
8.
9.
Huang, Hsi‐Chien, Yun‐Chieh Sung, Chung‐Pin Li, et al.. (2021). Reversal of pancreatic desmoplasia by a tumour stroma-targeted nitric oxide nanogel overcomes TRAIL resistance in pancreatic tumours. Gut. 71(9). 1843–1855. 39 indexed citations
10.
Wang, Yi‐Ping, et al.. (2021). NOTCH1 signaling promotes protein stability of HER3 through the AKT pathway in squamous cell carcinoma of head and neck. Oncogenesis. 10(8). 59–59. 1 indexed citations
11.
Liu, I-Ju, Hsiu-Ting Lin, Mei-Jung Wang, et al.. (2021). Identification of COVID-19 B-cell epitopes with phage-displayed peptide library. Journal of Biomedical Science. 28(1). 43–43. 18 indexed citations
12.
Chen, Liang‐Cheng, Serigne Lo, Mingwei Chen, et al.. (2020). Imaging and biodistribution of radiolabeled SP90 peptide in BT-483 tumor bearing mice. Applied Radiation and Isotopes. 161. 109162–109162. 2 indexed citations
13.
Lu, Ruei‐Min, et al.. (2020). Development of therapeutic antibodies for the treatment of diseases. Journal of Biomedical Science. 27(1). 1–1. 1397 indexed citations breakdown →
14.
Liang, Kang-Hao, Feng-Yi Ke, Yi‐Ting Chuang, et al.. (2018). Extracellular domain of EpCAM enhances tumor progression through EGFR signaling in colon cancer cells. Cancer Letters. 433. 165–175. 61 indexed citations
15.
Wu, Chien‐Hsun, I-Ju Liu, Ruei‐Min Lu, & Han‐Chung Wu. (2016). Advancement and applications of peptide phage display technology in biomedical science. Journal of Biomedical Science. 23(1). 8–8. 262 indexed citations
16.
Li, Pi‐Chun, et al.. (2015). An Epitope-Substituted DNA Vaccine Improves Safety and Immunogenicity against Dengue Virus Type 2. PLoS neglected tropical diseases. 9(7). e0003903–e0003903. 19 indexed citations
17.
Wang, Yi‐Ping, I-Ju Liu, Chun‐Pin Chiang, & Han‐Chung Wu. (2013). Astrocyte elevated gene-1 is associated with metastasis in head and neck squamous cell carcinoma through p65 phosphorylation and upregulation of MMP1. Molecular Cancer. 12(1). 109–109. 35 indexed citations
18.
Tsai, Wen-Yang, I-Ju Liu, Pi‐Chun Li, et al.. (2012). Analysis of Epitopes on Dengue Virus Envelope Protein Recognized by Monoclonal Antibodies and Polyclonal Human Sera by a High Throughput Assay. PLoS neglected tropical diseases. 6(1). e1447–e1447. 59 indexed citations
19.
Li, Pi‐Chun, Mei‐Ying Liao, Jian‐Jong Liang, et al.. (2012). Development of a Humanized Antibody with High Therapeutic Potential against Dengue Virus Type 2. PLoS neglected tropical diseases. 6(5). e1636–e1636. 29 indexed citations
20.
Liu, I-Ju, Chien‐Yu Chiu, Yunching Chen, & Han‐Chung Wu. (2011). Molecular Mimicry of Human Endothelial Cell Antigen by Autoantibodies to Nonstructural Protein 1 of Dengue Virus. Journal of Biological Chemistry. 286(11). 9726–9736. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026